Although the study by Yuan et al. [25] found no difference between syndecan-1 levels in patients with COVID-19 compared to controls, other 10 studies found significantly higher levels of syndecan-1 in COVID-19 patients in comparison to healthy individuals [15–24]. Here, SDC1 is linked to COVID-19.